Stock Analysis

Beijing Balance Medical TechnologyLtd (SHSE:688198) Will Be Hoping To Turn Its Returns On Capital Around

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Although, when we looked at Beijing Balance Medical TechnologyLtd (SHSE:688198), it didn't seem to tick all of these boxes.

Return On Capital Employed (ROCE): What Is It?

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. Analysts use this formula to calculate it for Beijing Balance Medical TechnologyLtd:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.069 = CN¥84m ÷ (CN¥1.3b - CN¥66m) (Based on the trailing twelve months to September 2024).

Therefore, Beijing Balance Medical TechnologyLtd has an ROCE of 6.9%. On its own, that's a low figure but it's around the 5.9% average generated by the Medical Equipment industry.

Check out our latest analysis for Beijing Balance Medical TechnologyLtd

roce
SHSE:688198 Return on Capital Employed December 20th 2024

In the above chart we have measured Beijing Balance Medical TechnologyLtd's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Beijing Balance Medical TechnologyLtd .

What Does the ROCE Trend For Beijing Balance Medical TechnologyLtd Tell Us?

When we looked at the ROCE trend at Beijing Balance Medical TechnologyLtd, we didn't gain much confidence. To be more specific, ROCE has fallen from 20% over the last five years. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. If these investments prove successful, this can bode very well for long term stock performance.

In Conclusion...

In summary, despite lower returns in the short term, we're encouraged to see that Beijing Balance Medical TechnologyLtd is reinvesting for growth and has higher sales as a result. And long term investors must be optimistic going forward because the stock has returned a huge 275% to shareholders in the last five years. So should these growth trends continue, we'd be optimistic on the stock going forward.

One more thing to note, we've identified 2 warning signs with Beijing Balance Medical TechnologyLtd and understanding these should be part of your investment process.

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Beijing Balance Medical TechnologyLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SHSE:688198

Beijing Balance Medical TechnologyLtd

Beijing Balance Medical Technology Co.,Ltd.

Exceptional growth potential with solid track record.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4035.0% undervalued
25 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6090.4% undervalued
24 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8151.3% undervalued
46 users have followed this narrative
4 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

GA
BUKS logo
GaryB on Butler National ·

Butler National (Buks) outperforms.

Fair Value:US$3.4419.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OS
oscargarcia
AVGO logo
oscargarcia on Broadcom ·

A tech powerhouse quietly powering the world’s AI infrastructure.

Fair Value:US$48025.0% undervalued
15 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AB
AbraxasAether
AJBU logo
AbraxasAether on Keppel DC REIT ·

Keppel DC REIT (SGX: AJBU) is a resilient gem in the data center space.

Fair Value:S$2.613.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8683.7% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3930.1% undervalued
965 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative